Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Left Ventricular Hypertrophy: later-stage trial registry
7 of 8 indexed Left Ventricular Hypertrophy trials are currently recruiting, with more weight in Phase 3-4.
Corpus placement: #2,176 of 28,707 conditions by registered trial count.
8 US clinical trials · 7 currently recruiting · #2,176 of 28,707 conditions by registered trial count
Left Ventricular Hypertrophy: 8 US clinical trials tracked, 7 recruiting.
Left Ventricular Hypertrophy is the subject of 8 registered US clinical trials on ClinicalTrials.gov, 7 of them currently open to new participants. 2 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Massachusetts General Hospital, running 2 of these trials.
Enrollment posture brief
Registry condition left-ventricular-hypertrophy
OPEN 7 | RECR 88% | LATE 2 | EARLY 1 | RANK #2176 | SPON 2
Volume-matched condition peers
Nearest open-share peer: Aortic Diseases (88% recruiting · 8 trials)
Left Ventricular Hypertrophy lists 7 open slots (88% of 8 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Left Ventricular Hypertrophy on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Left Ventricular Hypertrophy is recruiting above its size-band peers.
7 of 8 indexed trials (87.5%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Left Ventricular Hypertrophy research.
Massachusetts General Hospital accounts for 2 of 8 trials (25%). 7 distinct sponsors appear on at least one study for this condition label.
-
Typical Left Ventricular Hypertrophy enrolment sits around 160 participants.
Median target enrolment is 160 among the 8 trials that report a genuine target (sentinel values excluded). 2 of those (25%) plan for fewer than 100 participants.
-
Left Ventricular Hypertrophy research is mostly interventional.
6 interventional and 2 observational studies make up this index (75% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
8 total, page 1 of 1
Sodium Lowering Vascular Effects Trial
Tulane University
NCT05388032
Point-of-care Ultrasound and Treatment Disparities for Left Ventricular Hypertrophy
Yale University
NCT05730309
Diffusion MRI in Heart Failure
Massachusetts General Hospital
NCT02973633
US Benchmarking Clinical Study
eMyosound SAS
NCT07215715
Pediatric Hypertension and the Renin-Angiotensin SystEm (PHRASE)
Wake Forest University Health Sciences
NCT04752293
Imaging Histone Deacetylase in the Heart
Massachusetts General Hospital
NCT03549559
Mineralocorticoid Receptor, Coronary Microvascular Function, and Cardiac Efficiency in Hypertension
Brigham and Women's Hospital
NCT05593055
Aliskiren in Combination With Losartan Compared to Losartan on the Regression of Left Ventricular Hypertrophy in Overweight Patients With Essential Hypertension
Novartis Pharmaceuticals
NCT00219141
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
| Phase 3 | 1 |
| Phase 4 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Left Ventricular Hypertrophy records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Left Ventricular Hypertrophy trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Left Ventricular Hypertrophy page
8 registered trials, 7 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 7 Left Ventricular Hypertrophy trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Massachusetts General Hospital sponsors the most Left Ventricular Hypertrophy trials on record, review their full trial history before evaluating a specific study. See Massachusetts General Hospital's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Left Ventricular Hypertrophy condition card totals 8 registered trials; most-linked intervention Losartan 50/100 mg placebo; top US site state Massachusetts. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.